CARsgen Therapeutics Holdings Limited
CRTHF
$0.76
$0.01351.81%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 78.50% | 78.81% | -30.56% | -31.60% | 15.90% |
| Total Depreciation and Amortization | -- | -- | -13.74% | -13.06% | -- |
| Total Amortization of Deferred Charges | -- | -- | 14.25% | 15.14% | -- |
| Total Other Non-Cash Items | -226.56% | -224.73% | 190.25% | 190.97% | -57.68% |
| Change in Net Operating Assets | -- | -- | -74.79% | -74.59% | -- |
| Cash from Operations | 23.19% | 24.30% | 50.72% | 50.32% | -74.64% |
| Capital Expenditure | -- | -- | -1,543.82% | -1,557.62% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -474.29% | -477.14% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -73.91% | -74.29% | -95.57% | -95.54% | 101.61% |
| Cash from Investing | -73.91% | -74.29% | -98.66% | -98.65% | 101.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -212.07% | -212.07% | -- |
| Issuance of Common Stock | -- | -- | 1,869.80% | 1,869.80% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.04% | -220.04% | -55.35% | -55.35% | 1,065.51% |
| Cash from Financing | -220.22% | -218.48% | 57.28% | 56.93% | 418.38% |
| Foreign Exchange rate Adjustments | -78.28% | -78.59% | -139.27% | -139.58% | 187.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.85% | -9.26% | -205.04% | -205.88% | 67.33% |